Analysts: Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

55.26USD
22 Jul 2014
Price Change (% chg)

$1.15 (+2.13%)
Prev Close
$54.11
Open
$54.72
Day's High
$56.11
Day's Low
$54.16
Volume
456,377
Avg. Vol
912,290
52-wk High
$112.57
52-wk Low
$43.23

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.56 December 23 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 4 4 4 4
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 6 11.07 19.97 8.38 8.70
Quarter Ending Dec-14 6 11.07 19.97 8.38 8.70
Year Ending Dec-14 9 40.24 68.18 33.43 37.36
Year Ending Dec-15 7 42.10 70.00 21.90 56.50
Earnings (per share)
Quarter Ending Sep-14 6 -0.56 -0.48 -0.72 -0.47
Quarter Ending Dec-14 6 -0.59 -0.54 -0.70 -0.45
Year Ending Dec-14 4 -2.93 -1.79 -5.03 -1.75
Year Ending Dec-15 8 -2.36 -1.09 -3.27 -1.69

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-14 10.80 8.27 2.53 23.41
Quarter Ending Dec-13 9.98 10.85 0.87 8.73
Quarter Ending Sep-13 8.64 8.99 0.35 4.03
Quarter Ending Jun-13 8.99 8.69 0.31 3.40
Quarter Ending Mar-13 15.56 18.64 3.09 19.83
Earnings (per share)
Quarter Ending Mar-14 -0.54 -0.39 0.15 -27.44
Quarter Ending Dec-13 -0.45 -0.51 0.06 -13.33
Quarter Ending Sep-13 -0.39 -0.48 0.09 -24.00
Quarter Ending Jun-13 -0.35 -0.29 0.06 -16.35
Quarter Ending Mar-13 -0.29 -0.16 0.13 -44.27

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 11.07 11.07 11.07 11.07 8.70
Quarter Ending Dec-14 11.07 11.07 11.07 11.07 8.70
Year Ending Dec-14 40.24 40.24 40.24 40.24 37.36
Year Ending Dec-15 42.10 42.10 42.12 42.12 56.50
Earnings (per share)
Quarter Ending Sep-14 -0.56 -0.56 -0.56 -0.56 -0.47
Quarter Ending Dec-14 -0.59 -0.59 -0.59 -0.59 -0.45
Year Ending Dec-14 -2.93 -2.93 -2.87 -2.87 -1.75
Year Ending Dec-15 -2.36 -2.36 -2.43 -2.43 -1.69

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 1
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks